# Extracranial Carotid Artery Disease: Pathophysiology and Natural History

## Overview

Atherosclerotic disease affecting the carotid bifurcation accounts for approximately 20-25% of all ischemic strokes. Stroke ranks as the fifth leading cause of death and is the foremost cause of long-term disability in the United States. Therefore, a thorough understanding of the pathophysiology, natural history, and risk stratification of carotid artery disease is crucial for selecting appropriate patients for intervention.

## Anatomy

The common carotid artery (CCA) has distinct origins on each side: the left CCA arises directly from the aortic arch, while the right CCA originates from the innominate artery. The carotid bifurcation typically occurs at the level of the C3-C4 vertebrae, corresponding to the upper border of the thyroid cartilage. At this bifurcation, the internal carotid artery (ICA) continues without extracranial branches and supplies the brain through the middle cerebral and anterior cerebral arteries. In contrast, the external carotid artery (ECA) supplies the face and scalp and also provides collateral blood flow to the brain via ophthalmic artery anastomoses. The carotid bulb, a focal dilation at the origin of the ICA, houses the carotid body, a chemoreceptor, and the carotid sinus, a baroreceptor. Atherosclerosis preferentially affects the carotid bulb and the proximal ICA, largely due to disturbed flow patterns in these regions.

## Pathophysiology of Carotid Atherosclerosis

### Hemodynamic Factors

The carotid bifurcation is a site prone to flow separation and experiences low or oscillatory wall shear stress, particularly along the outer wall of the ICA bulb. This low shear stress environment promotes endothelial dysfunction, increases permeability to lipoproteins, facilitates inflammatory cell adhesion, and ultimately contributes to plaque development.

### Plaque Development

Carotid plaque formation follows the same progression observed in systemic atherosclerosis, beginning with fatty streaks, advancing to fibrous cap atheromas, and eventually evolving into complex plaques. These plaques may be stable, characterized by a fibrous cap and calcification, or vulnerable and unstable, which are more prone to rupture.

### Mechanisms of Stroke from Carotid Disease

Stroke resulting from carotid disease primarily occurs through thromboembolism, the most common mechanism. Plaque rupture or ulceration leads to platelet aggregation and embolization to the intracranial circulation. Artery-to-artery embolism can also occur when cholesterol crystals or thrombus fragments detach from the plaque surface. Less commonly, severe stenosis or occlusion causes hemodynamic compromise, reducing cerebral perfusion, especially in the setting of poor collateral circulation. Acute thrombotic occlusion may result from plaque rupture causing complete ICA occlusion.

<image>Cross-sectional illustration of the carotid bifurcation showing flow separation patterns with areas of low wall shear stress at the outer wall of the ICA bulb, and progression from normal endothelium to fatty streak, fibrous cap atheroma, and vulnerable plaque with a thin cap and large lipid core</image>

## Plaque Morphology and Vulnerability

### Features of Vulnerable Plaque

Vulnerable plaques are characterized by a thin fibrous cap measuring less than 65 micrometers, a large lipid-rich necrotic core, intraplaque hemorrhage, plaque ulceration or surface irregularity, active inflammation with macrophage infiltration, and neovascularization within the plaque.

### Stable Plaque Features

In contrast, stable plaques have a thick fibrous cap, heavy calcification, a small lipid core, a smooth plaque surface, and minimal inflammation.

### Imaging of Plaque Morphology

Duplex ultrasound can differentiate echolucent plaques, which are lipid-rich and vulnerable, from echogenic or calcified plaques that are more stable. Gray-scale median (GSM) analysis is used to quantify this. Magnetic resonance imaging (MRI) plaque imaging is considered the gold standard for non-invasive plaque characterization; T1-weighted sequences detect intraplaque hemorrhage as hyperintense signals and can identify the lipid core, fibrous cap status, and inflammation. Contrast-enhanced ultrasound (CEUS) detects neovascularization within plaques, while 18F-FDG PET/CT identifies metabolically active, inflamed plaques.

## Definitions: Symptomatic vs. Asymptomatic

### Symptomatic Carotid Stenosis

Symptomatic carotid stenosis refers to neurologic symptoms attributable to the ipsilateral carotid territory occurring within the preceding six months. These symptoms include transient ischemic attacks (TIAs), which are focal neurologic deficits lasting less than 24 hours, typically under one hour; amaurosis fugax, which is transient monocular visual loss due to emboli to the ophthalmic artery; and stroke, defined as a fixed neurologic deficit lasting more than 24 hours or imaging evidence of infarction. It is important that symptoms be ipsilateral to the carotid stenosis and to distinguish these from posterior circulation symptoms arising from the vertebrobasilar system.

### Asymptomatic Carotid Stenosis

Asymptomatic carotid stenosis is identified incidentally or through screening in patients without referable neurologic events. The annual stroke risk in these patients is approximately 1-2% per year with modern medical therapy, a reduction from historical rates of 2-3%.

## Natural History

### Symptomatic Stenosis

Data from the North American Symptomatic Carotid Endarterectomy Trial (NASCET) show that the two-year stroke risk for symptomatic stenosis is 22% for 50-69% stenosis and 26% for 70-99% stenosis in patients receiving medical therapy alone. The risk is highest within the first two to four weeks following the index event, reaching up to 10-15%. This elevated risk necessitates urgent intervention for symptomatic stenosis.

### Asymptomatic Stenosis

The Asymptomatic Carotid Atherosclerosis Study (ACAS) and the Asymptomatic Carotid Surgery Trial (ACST) reported an annual stroke risk of about 2% with medical therapy in the 1990s. With modern medical therapy, including optimal statin use, antiplatelet agents, and blood pressure control, the annual stroke risk is likely less than 1%. This improvement in medical management has fueled ongoing debate regarding the benefits of intervention in asymptomatic patients.

### Risk Factors for Progression

Risk factors that contribute to progression of carotid stenosis include continued smoking, diabetes, hyperlipidemia, the severity of baseline stenosis, contralateral ICA occlusion, and plaque morphology features such as echolucency and ulceration.

<image>Graph showing the natural history of carotid artery stenosis comparing annual stroke risk for symptomatic versus asymptomatic disease across different degrees of stenosis (50-99%), with data from NASCET, ACAS, and contemporary medical therapy studies overlaid</image>

## Grading of Stenosis

### NASCET Method (Most Commonly Used)

The NASCET method calculates percent stenosis as (1 minus the ratio of the narrowest ICA diameter to the normal distal ICA diameter) multiplied by 100. This method compares the narrowest point of the stenosis to the normal distal ICA.

### ECST Method

The European Carotid Surgery Trial (ECST) method calculates percent stenosis as (1 minus the ratio of the narrowest ICA diameter to the estimated original bulb diameter) multiplied by 100. This approach compares the narrowest point to the estimated original vessel diameter at the bulb and generally yields higher stenosis values than NASCET for the same lesion.

### Duplex Ultrasound Velocity Criteria (Consensus Panel)

Duplex ultrasound uses velocity criteria to estimate stenosis severity. For less than 50% stenosis, peak systolic velocity (PSV) is under 125 cm/s, end-diastolic velocity (EDV) is under 40 cm/s, and the ICA/CCA PSV ratio is less than 2.0. For 50-69% stenosis, PSV ranges from 125 to 230 cm/s, EDV from 40 to 100 cm/s, and the ICA/CCA PSV ratio from 2.0 to 4.0. For stenosis of 70% or greater, PSV exceeds 230 cm/s, EDV is over 100 cm/s, and the ICA/CCA PSV ratio is greater than 4.0. Near occlusion shows variable velocities, which may be low, and total occlusion is characterized by no detectable flow.

## Risk Stratification

Beyond stenosis severity, several high-risk features increase stroke risk. These include recent symptoms within two weeks, echolucent or ulcerated plaques, contralateral ICA occlusion, impaired cerebrovascular reserve as assessed by transcranial Doppler with CO2 reactivity, silent brain infarcts on MRI ipsilateral to the stenosis, microembolic signals detected on transcranial Doppler, and progressive stenosis on serial imaging.

## Clinical Pearls

Carotid stenosis causes stroke primarily through embolism rather than hemodynamic compromise, making plaque characteristics as important as the degree of stenosis. Symptomatic carotid stenosis constitutes a vascular emergency because the highest stroke risk occurs within the first two to four weeks after the event, necessitating urgent intervention. The NASCET method remains the standard for reporting stenosis severity, and familiarity with duplex ultrasound velocity criteria is essential. Advances in medical therapy have improved the natural history of asymptomatic carotid stenosis, narrowing the benefit of intervention in these patients. Advanced plaque imaging modalities such as MRI and contrast-enhanced ultrasound may help identify asymptomatic patients at high risk who could benefit from intervention. It is always critical to confirm that neurologic symptoms are ipsilateral and within the carotid territory before attributing them to carotid stenosis.

## References
- NASCET Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325(7):445-453.
- ACAS Executive Committee. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421-1428.
- Halliday A, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1). Lancet. 2010;376(9746):1074-1084.
- Grant EG, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis. Radiology. 2003;229(2):340-346.
- Spence JD, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33(12):2916-2922.